Teva Price News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget News provided by Share this article Share this article TORONTO, April 20, 2021 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., strongly welcomes the Government of Canada's commitment in the April 19, 2021 federal budget to support Canada's life science sector. The Budget includes $2.2 billion over seven years "towards growing a vibrant domestic life sciences sector" and will be part of the plan "to build domestic resilience and improve long-term pandemic preparedness". Christin...

Published: Apr 08, 2021 Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults AJOVY® now offers patients greater flexibility with two dosing options available in both an autoinjector and a prefilled syringe AJOVY® is the first and only subcutaneous anti-CGRP treatment with both quarterly (every three months) and monthly dosing options using either the autoinjector or prefilled syringe for the preventive treatment of migraine in adults. AJOVY® is supported by the AJOVY® Teva Support Solutions® (AJOVY® TSS) Patient Support Program, whose...